Thye Dirk
- SEC CIK
- 0001638945
No open-market purchases or sales filed in the past year.
Current role at each company
- QNCX Quince Therapeutics, Inc.CEO and CMOas of Jan 23, 2026
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Thye Dirk as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Sep 3, 2024 (view filing) | Aug 29-30 | 5 days | Thye DirkCEO AND CHIEF MEDICAL OFFICER | PPurchase | +154.5K | $0.695 | +$107.4K | +22.4%843.9K after | 2 lots |
| Aug 11, 2023 (view filing) | Aug 10 | 1 day | Thye DirkChief Executive Officer | PPurchase | +88.0K | $1.26 | +$110.9K | +24.4%448.9K after | |
| Aug 9, 2023 (view filing) | Aug 8 | 1 day | Thye DirkChief Executive Officer | PPurchase | +80.0K | $1.24 | +$99.2K | +28.5%360.9K after |